Dr Shakesha Montina Evans, PHD | |
16160 Midway Rd Ste 218, Addison, TX 75001-4207 | |
(469) 680-3500 | |
Not Available |
Full Name | Dr Shakesha Montina Evans |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 16160 Midway Rd Ste 218, Addison, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174841910 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 201620 (Texas) | Secondary |
103TC0700X | Psychologist - Clinical | 37933 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Shakesha Montina Evans, PHD 309 Sandy Creek Dr, Desoto, TX 75115-5390 Ph: (580) 284-6809 | Dr Shakesha Montina Evans, PHD 16160 Midway Rd Ste 218, Addison, TX 75001-4207 Ph: (469) 680-3500 |
News Archive
The new year has brought with it advances to the Society of Toxicology's official journal, Toxicological Sciences, some of which are reflected in the January 2020 issue-;Volume 173, Issue 1.
Bowel screening reduces the number of deaths from bowel cancer in Scotland by more than 25 per cent, according to research* presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week.
Tufts University announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Charlie Mace, assistant professor of chemistry in the School of Arts and Sciences at Tufts University, will pursue research that could potentially revolutionize the way blood samples are analyzed and stored in the field.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Centro Ricerche Cliniche di Verona, a leading Early Phase Clinical Research facility, today announced that it has become the first organization to be accredited under a new scheme of quality certification conducted by EUCROF (European CROs Federation).
› Verified 8 days ago